Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis

被引:105
作者
Irminger-Finger, I [1 ]
Leung, WC
Li, J
Dubois-Dauphin, M
Harb, J
Feki, A
Jefford, CE
Soriano, JV
Jaconi, M
Montesano, R
Krause, KH
机构
[1] Univ Geneva, Fac Med, Biol Aging Lab, Dept Geriatr, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Fac Med, Dept Psychiat, CH-1211 Geneva 4, Switzerland
[3] Univ Geneva, Fac Med, Dept Obstet & Gynecol, CH-1211 Geneva 4, Switzerland
[4] Univ Geneva, Fac Med, Dept Morphol, CH-1211 Geneva 4, Switzerland
[5] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA
[6] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA
[7] INSERM, Inst Biol, U419, Nantes, France
关键词
D O I
10.1016/S1097-2765(01)00406-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The BRCA1-associated protein BARD1 is a putative tumor suppressor. We suggest that BARD1 is a mediator of apoptosis since (1) cell death in vivo (ischemic stroke) and in vitro is accompanied by increased levels of BARD1 protein and mRNA; (2) overexpression of BARD1 induces cell death with all features of apoptosis; and (3) BARD1-repressed cells are defective for the apoptotic response to genotoxic stress. The proapoptotic activity of BARD1 involves binding to and elevations of p53. BRCA1 is not required for but partially counteracts apoptosis induction by BARD1. A tumor-associated mutation Q564H of BARD1 is defective in apoptosis induction, thus suggesting a role of BARD1 in tumor suppression by mediating the signaling from proapoptotic stress toward induction of apoptosis.
引用
收藏
页码:1255 / 1266
页数:12
相关论文
共 34 条
[1]  
AHSHIZUME R, 2001, J BIOL CHEM, V276, P14537
[2]   BRCA1 is a selective co-activator of 14-3-3σ gene transcription in mouse embryonic stem cells [J].
Aprelikova, O ;
Pace, AJ ;
Fang, B ;
Koller, BH ;
Liu, ET .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :25647-25650
[3]   Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein [J].
Ayi, TC ;
Tsan, JT ;
Hwang, LY ;
Bowcock, AM ;
Baer, R .
ONCOGENE, 1998, 17 (16) :2143-2148
[4]  
Bienstock RJ, 1996, CANCER RES, V56, P2539
[5]  
Buller RE, 2001, CLIN CANCER RES, V7, P831
[6]   P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells [J].
Corbet, SW ;
Clarke, AR ;
Gledhill, S ;
Wyllie, AH .
ONCOGENE, 1999, 18 (08) :1537-1544
[7]   ULTRASTRUCTURE OF THE NORMAL MENSTRUAL-CYCLE - A REVIEW [J].
FERENCZY, A .
MICROSCOPY RESEARCH AND TECHNIQUE, 1993, 25 (02) :91-105
[8]   Ubiquitination: RING for destruction? [J].
Freemont, PS .
CURRENT BIOLOGY, 2000, 10 (02) :R84-R87
[9]  
Gautier F, 2000, CANCER RES, V60, P6895
[10]  
Greenblatt MS, 2001, CANCER RES, V61, P4092